Professor Kim Dayton's Elder Law Prof Blog has an interesting note about a proposed bi-partisan amendment to S. 3187, the Food and Drug Administration Safety and Innovation Act, that would require informed consent before anti-psychotic medications are prescribed to nursing home patients with dementia. This is important, because too many nursing homes prescribe anti psychotic medication merely to control patients who would otherwise require staff attention.
No comments:
Post a Comment